The Aquaculture Therapeutics Market is projected to reach the valuation of USD 1.9 billion in 2025 and USD 3.8 billion by 2035, growing at a CAGR of 7.2% over the forecast period. Anti-Infectives to lead the product type segment, capturing a 29.3% revenue share. Finfish will remain the dominant in species segment, accounting for a 67.4% market share.